Literature DB >> 17976098

Cardiac resynchronization therapy: gender related differences in left ventricular reverse remodeling.

Alessio Lilli1, Giuseppe Ricciardi, Maria Cristina Porciani, Alessandro Paoletti Perini, Paolo Pieragnoli, Nicola Musilli, Andrea Colella, Stefano Del Pace, Antonio Michelucci, Federico Turreni, Massimo Sassara, Augusto Achilli, S Serge Barold, Luigi Padeletti.   

Abstract

AIM: Gender related differences in epidemiology, treatment, and prognosis of heart failure (HF) have been reported. We examined the sex influence in patients treated with cardiac resynchronization therapy (CRT). METHODS AND
RESULTS: Out of 334 consecutive HF patients (19.7% women) who underwent CRT, 195 patients reached clinical and echocardiographic evaluation at six and 12 months and were selected for analysis. A reduction in left ventricular (LV) end-diastolic volume/m(2) (EDVi) and end systolic volume/m(2) (ESVi) was evident in the overall population at six months (P < 0.001) and from six to 12 months (P < 0.001). Compared to men, women showed significantly greater changes in LV volumes at mid (P < 0.05) and long-term (P < 0.001) follow-up and a significantly higher LV ejection fraction (EF) (40.8 +/- 12.3 vs 34.1 +/- 10.1, P < 0.01) at one year. Multiple regression analysis, including several demographic and clinical parameters, revealed that female gender is independently associated with greater reduction in LV ESVi. At the 12-month follow-up, the proportion of responders (defined in terms of ESV reduction by at least 10%) was higher in women than in men (76.1% vs 59.3%, P < 0.05).
CONCLUSIONS: CRT induced a gender specific LV remodeling response.

Entities:  

Mesh:

Year:  2007        PMID: 17976098     DOI: 10.1111/j.1540-8159.2007.00870.x

Source DB:  PubMed          Journal:  Pacing Clin Electrophysiol        ISSN: 0147-8389            Impact factor:   1.976


  9 in total

1.  Effectiveness of cardiac resynchronization therapy in diabetic patients with ischemic and nonischemic cardiomyopathy.

Authors:  Jenie George; Alon Barsheshet; Arthur J Moss; David Martin; Gregory Ouellet; Scott McNitt; Ilan Goldenberg
Journal:  Ann Noninvasive Electrocardiol       Date:  2012-01       Impact factor: 1.468

Review 2.  Clinical, laboratory, and pacing predictors of CRT response.

Authors:  Jagdesh Kandala; Robert K Altman; Mi Young Park; Jagmeet P Singh
Journal:  J Cardiovasc Transl Res       Date:  2012-02-24       Impact factor: 4.132

Review 3.  Arrhythmias in women.

Authors:  Anne B Curtis; Deepika Narasimha
Journal:  Clin Cardiol       Date:  2012-03       Impact factor: 2.882

Review 4.  Controversies in cardiac resynchronization therapy: do sex differences in response exist?

Authors:  Robin E Germany; Toni L Ripley
Journal:  Curr Heart Fail Rep       Date:  2011-03

Review 5.  Sex differences in device therapy for heart failure: utilization, outcomes, and adverse events.

Authors:  Naomi D Herz; Joseph Engeda; Robbert Zusterzeel; William E Sanders; Kathryn M O'Callaghan; David G Strauss; Samantha B Jacobs; Kimberly A Selzman; Ileana L Piña; Daniel A Caños
Journal:  J Womens Health (Larchmt)       Date:  2015-03-20       Impact factor: 2.681

6.  Outcomes in Women Undergoing Electrophysiological Procedures.

Authors:  Pasquale Santangeli; Luigi Di Biase; Eloisa Basile; Amin Al-Ahmad; Andrea Natale
Journal:  Arrhythm Electrophysiol Rev       Date:  2013-04

7.  Sex Differences in Utilisation and Response to Implantable Device Therapy.

Authors:  Deepika Narasimha; Anne B Curtis
Journal:  Arrhythm Electrophysiol Rev       Date:  2015-08

8.  Sex-specific mortality differences in heart failure patients with ischemia receiving cardiac resynchronization therapy.

Authors:  Zhonglin Han; Zheng Chen; Rongfang Lan; Wencheng Di; Xiaohong Li; Hongsong Yu; Wenqing Ji; Xinlin Zhang; Biao Xu; Wei Xu
Journal:  PLoS One       Date:  2017-07-06       Impact factor: 3.240

Review 9.  The impact of gender difference on clinical and echocardiographic outcomes in patients with heart failure after cardiac resynchronization therapy: A systematic review and meta-analysis.

Authors:  Fa-Hui Yin; Chun-Lei Fan; Ya-Ya Guo; Hai Zhu; Zhi-Lu Wang
Journal:  PLoS One       Date:  2017-04-28       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.